FDA 483 - RK Pharma Inc., - November 14, 2025

RK Pharma Inc., an analytical testing laboratory in East Windsor, NJ, received a Form 483 with four observations. The inspection revealed significant deficiencies in equipment qualification, data integrity controls, quality unit procedures, and employee training. These issues indicate a lack of adherence to current good manufacturing practices, potentially impacting the quality and reliability of their analytical testing.